New antifungal agent data

摘要

Posaconazole (Noxafil),a new triazole anti-fungal agent,has demonstrated superior efficacy to fluconazole in preventing aspergillosis in allogeneic haematopoietic stem cell transplant recipients with graft versus host disease.